blank Quick help
blank Maintenance news
blank News flashes
blank Related links

Extract from the Register of European Patents

EP About this file: EP0609210

EP0609210 - OPTICALLY ACTIVE 5H-PYRROLO[3,4-b]PYRAZINE DERIVATIVE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.02.1996
Database last updated on 05.05.2025
Most recent event   Tooltip16.02.1996No opposition filed within time limitpublished on 03.04.1996 [1996/14]
Applicant(s)For all designated states
Aventis Pharma S.A.
20, avenue Raymond Aron
92160 Antony / FR
[N/P]
Inventor(s)01 / COTREL, Claude
17, avenue du Docteur-Arnold-Netter
F-75012 Paris / FR
02 / ROUSSEL, Gérard
20 ter, rue des Carrières
F-91450 Soisy-sur-Seine / FR
[1994/32]
Representative(s)Pilard, Jacques
RHONE-POULENC RORER S.A. Direction Brevets 20 avenue Raymond Aron
92165 Antony Cédex / FR
[N/P]
Application number, filing date92903994.916.01.1992
[1994/32]
WO1992FR00031
Priority number, dateFR1991000049017.01.1991         Original published format: FR 9100490
[1994/32]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO9212980
Date:06.08.1992
Language:FR
[1992/21]
Type: A1 Application with search report 
No.:EP0609210
Date:10.08.1994
Language:FR
The application published by WIPO in one of the EPO official languages on 06.08.1992 takes the place of the publication of the European patent application.
[1994/32]
Type: B1 Patent specification 
No.:EP0609210
Date:12.04.1995
Language:FR
[1995/15]
Search report(s)International search report - published on:EP06.08.1992
(Supplementary) European search report - dispatched on:EP17.09.1993
ClassificationIPC:C07D487/04, C07B57/00, A61K31/50, // (C07D487/04, 241:00, 209:00)
[1994/32]
CPC:
C07D487/04 (EP,US); A61P25/08 (EP); A61P25/20 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   PT,   SE [1994/38]
TitleGerman:OPTISCH AKTIVES 5H-PYRROLO[3,4-b]PYRAZINDERIVAT, SEINE HERSTELLUNG UND PHARMAZEUTISCHE ZUBEREITUNGEN DIE ES ENTHALTEN[1995/15]
English:OPTICALLY ACTIVE 5H-PYRROLO[3,4-b]PYRAZINE DERIVATIVE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT[1995/15]
French:DERIVE DE LA 5H-PYRROLO[3,4-b]PYRAZINE OPTIQUEMENT ACTIF, SA PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LE CONTIENNENT[1995/15]
MiscellaneousEPB 1994/39: Verbunden mit 92400111.8/0495717 (europäische Anmeldenummer/Veröffentlichungsnummer) durch Entscheidung vom 11.08.94
EPB 1994/39: Consolidated with 92400111.8/0495717 (European application No./publication No.) by decision dated 11.08.94
EPB 1994/39: Jointe à la demande no. 92400111.8/0495717 (numéro de dépôt/numéro de publication de la demande européenne) par décision du 11.08.94
Entry into regional phase13.07.1993National basic fee paid 
20.01.1992Designation fee(s) paid 
13.07.1993Examination fee paid 
Examination procedure16.05.1992Request for preliminary examination filed
International Preliminary Examining Authority: DE
13.07.1993Examination requested  [1994/32]
16.09.1994Despatch of communication of intention to grant (Approval: Yes)
14.10.1994Communication of intention to grant the patent
11.11.1994Fee for grant paid
11.11.1994Fee for publishing/printing paid
Opposition(s)13.01.1996No opposition filed within time limit [1996/14]
Fees paidRenewal fee
26.01.1994Renewal fee patent year 03
25.01.1995Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]DE2300491  (RHONE POULENC SA);
 [A]US4220646  (COTREL CLAUDE [FR], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.